Smart Biomarkers to Empower Drug Development for Brain Diseases
Press release from DZNE: Dresden Researchers Awarded Prestigious Funding by the Helmholtz Association to Validate a Novel Approach that Combines Neuroelectronics and Artificial Intelligence

